[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/34820,2015,A1
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/34820,2015,A1
[1]Patent:WO2015/34820,2015,A1
[1]JournalofMedicinalChemistry,2019,vol.62,p.7250-7263
[2]Patent:WO2015/34820,2015,A1.Locationinpatent:Page/Pagecolumn71-72
[1]JournalofMedicinalChemistry,2019,vol.62,p.7250-7263
Title: Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1.
Journal: Journal of medicinal chemistry 20170713
Title: Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).
Journal: Oncotarget 20160524
Title: Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
Journal: ACS chemical neuroscience 20150819